Literature DB >> 18956471

Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification.

Taigang He1, Peter D Gatehouse, Gillian C Smith, Raad H Mohiaddin, Dudley J Pennell, David N Firmin.   

Abstract

Reproducible and accurate myocardial T2* measurements are required for the quantification of iron in heart tissue in transfused thalassemia. The aim of this study was to determine the best method to measure the myocardial T2* from multi-gradient-echo data acquired both with and without black-blood preparation. Sixteen thalassemia patients from six centers were scanned twice locally, within 1 week, using an optimized bright-blood T2* sequence and then subsequently scanned at the standardization center in London within 4 weeks, using a T2* sequence both with and without black-blood preparation. Different curve-fitting models (monoexponential, truncation, and offset) were applied to the data and the results were compared by means of reproducibility. T2* measurements obtained using the bright- and black-blood techniques. The black-blood data were well fitted by the monoexponential model, which suggests that a more accurate measure of T2* can be obtained by removing the main source of errors in the bright-blood data. For bright-blood data, the offset model appeared to underestimate T2* values substantially and was less reproducible. The truncation model gave rise to more reproducible T2* measurements, which were also closer to the values obtained from the black-blood data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956471      PMCID: PMC2593631          DOI: 10.1002/mrm.21744

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  17 in total

1.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

2.  Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia.

Authors:  Mark A Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Christine H Lorenz; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-11       Impact factor: 4.813

3.  Improved R2* measurements in myocardial iron overload.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

4.  Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload.

Authors:  Alessia Pepe; Vincenzo Positano; Maria Filomena Santarelli; Fortunato Sorrentino; Eliana Cracolici; Daniele De Marchi; Aurelio Maggio; Massimo Midiri; Luigi Landini; Massimo Lombardi
Journal:  J Magn Reson Imaging       Date:  2006-05       Impact factor: 4.813

5.  Myocardial T*2 measurement in iron-overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification.

Authors:  Taigang He; Peter D Gatehouse; Paul Kirk; Raad H Mohiaddin; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2008-08       Impact factor: 4.668

6.  In vivo measurement of T*2 and field inhomogeneity maps in the human heart at 1.5 T.

Authors:  S B Reeder; A Z Faranesh; J L Boxerman; E R McVeigh
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

7.  Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia.

Authors:  Mark A Westwood; David N Firmin; Matta Gildo; Galanello Renzo; Gotsis Stathis; Karagiorga Markissia; Berdoukas Vasili; Dudley J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2005-10       Impact factor: 2.357

8.  Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*.

Authors:  Alessia Pepe; Massimo Lombardi; Vincenzo Positano; Eliana Cracolici; Marcello Capra; Roberto Malizia; Luciano Prossomariti; Daniele De Marchi; Massimo Midiri; Aurelio Maggio
Journal:  Eur J Haematol       Date:  2006-03       Impact factor: 2.997

9.  Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.

Authors:  Dudley J Pennell; Vasili Berdoukas; Markissia Karagiorga; Vasili Ladis; Antonio Piga; Athanassios Aessopos; Efstathios D Gotsis; Mark A Tanner; Gill C Smith; Mark A Westwood; Beatrix Wonke; Renzo Galanello
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

10.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

View more
  52 in total

1.  Comparison of myocardial T1 and T2 values in 3 T with T2* in 1.5 T in patients with iron overload and controls.

Authors:  Gabriel C Camargo; Tamara Rothstein; Flavia P Junqueira; Elsa Fernandes; Andreas Greiser; Ralph Strecker; Viviani Pessoa; Ronaldo S L Lima; Ilan Gottlieb
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

2.  Fast quantitative parameter maps without fitting: Integration yields accurate mono-exponential signal decay rates.

Authors:  Ruitian Song; Ralf B Loeffler; Joseph L Holtrop; M Beth McCarville; Jane S Hankins; Claudia M Hillenbrand
Journal:  Magn Reson Med       Date:  2017-10-30       Impact factor: 4.668

3.  Cardiac R2* values are independent of the image analysis approach employed.

Authors:  Antonella Meloni; Hugh Young Rienhoff; Amber Jones; Alessia Pepe; Massimo Lombardi; John C Wood
Journal:  Magn Reson Med       Date:  2013-10-01       Impact factor: 4.668

4.  Heart and liver T2 assessment for iron overload using different software programs.

Authors:  Juliano L Fernandes; Erika Fontana Sampaio; Monica Verissimo; Fabricio B Pereira; Jose Alvaro da Silva; Gabriel S de Figueiredo; Jose M Kalaf; Otavio R Coelho
Journal:  Eur Radiol       Date:  2011-08-13       Impact factor: 5.315

5.  An online open-source tool for automated quantification of liver and myocardial iron concentrations by T2* magnetic resonance imaging.

Authors:  K-A Git; L A B Fioravante; J L Fernandes
Journal:  Br J Radiol       Date:  2015-06-29       Impact factor: 3.039

Review 6.  Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart.

Authors:  Taigang He
Journal:  Quant Imaging Med Surg       Date:  2014-10

7.  International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers.

Authors:  Paul Kirk; Taigang He; Lisa J Anderson; Michael Roughton; Mark A Tanner; Wynnie W M Lam; Wing Y Au; Winnie C W Chu; Godfrey Chan; Renzo Galanello; Gildo Matta; Mark Fogel; Alan R Cohen; Ru San Tan; Kevin Chen; Ivy Ng; Angie Lai; Suthat Fucharoen; Jiraporn Laothamata; Suporn Chuncharunee; Sutipong Jongjirasiri; David N Firmin; Gillian C Smith; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

8.  Quantitative susceptibility mapping in multiple sclerosis.

Authors:  Christian Langkammer; Tian Liu; Michael Khalil; Christian Enzinger; Margit Jehna; Siegrid Fuchs; Franz Fazekas; Yi Wang; Stefan Ropele
Journal:  Radiology       Date:  2013-01-11       Impact factor: 11.105

9.  Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors.

Authors:  Moriel H Vandsburger; Marina Radoul; Yoseph Addadi; Senzeni Mpofu; Batya Cohen; Raya Eilam; Michal Neeman
Journal:  Radiology       Date:  2013-06-25       Impact factor: 11.105

Review 10.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.